TITLE

LOW DOSE INHALED CORTICOSTEROIDS AND THE PREVENTION OF DEATH FROM ASTHMA

AUTHOR(S)
Kips, J. C.; Pauwels, R. A.
PUB. DATE
September 2001
SOURCE
Thorax;Sep2001 Supp, Vol. 56, pii74
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Although inhaled corticosteroids are effective for the treatment of asthma, it is uncertain whether their use can prevent death from asthma. Methods: We used the Saskatchewan Health data bases to form a population-based cohort of all subjects from 5-44 years of age who were using antiasthma drugs during the period 1975-1991. We followed subjects until the end of 1997, their 55th birthday, death, emigration, or termination of health insurance coverage, whichever came first We conducted a nested case-control study in which subjects who died of asthma were matched with controls within the cohort according to the length of follow-up at the time of death of the case patient (the index date), the date of study entry, and the severity of asthma. We calculated rate ratios after adjustment for the subject's age and sex; the number of prescriptions of theophylline, nebulized and oral beta-adrenergic agonists, and oral corticosteroids in the year before the index date; the number of canisters of inhaled beta-adrenergic agonists used in the year before the index date; and the number of hospitalizations for asthma in the two years before the index date. Results: The cohort consisted of 30,569 subjects. Of the 562 deaths, 77 were classified as due to asthma. We matched the 66 subjects who died of asthma for whom there were complete data with 2681 controls. Fifty-three percent of the case patients and 46% of the control patients had used inhaled corticosteroids in the previous year, most commonly low-dose beclomethasone. The mean number of canisters was 1.18 for the patients who died and 1.57 for the controls. On the basis of a continuous dose-response analysis, we calculated that the rate of death from asthma decreased by 2% with each additional canister of inhaled corticosteroids used in the previous year (adjusted rate ratio 0.79; 95% confidence interval 0.65 to 0.97). The rate of death from asthma during the first three months after discontinuation of inhaled corticosteroids was higher than the rate among patients who continued to use the drugs. Conclusions: The regular use of low-dose inhaled corticosteroids is associated with a decreased risk of death from asthma.
ACCESSION #
12915399

 

Related Articles

  • Quality-of-life and asthma control with low-dose inhaled corticosteroids. Roberts, June; Williams, Angela // British Journal of Nursing;10/28/2004, Vol. 13 Issue 19, p1124 

    Guidelines are available to assist healthcare professionals in the appropriate management of patients with asthma, a highly prevalent and debilitating disease. Despite these guidelines many patients are still not being optimally treated, often resulting in poor asthma control and consequent...

  • Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study. dal Negro, Roberto; Piskorz, Peter; Vives, Roberto; Guilera, Magda; Kocevar, Vasilisa Sazonov; Badia, Xavier; Sazonov Kocevar, Vasilisa // PharmacoEconomics;2007, Vol. 25 Issue 8, p665 

    Objective: To evaluate the healthcare resource use and costs associated with adding montelukast to therapy in patients with mild to moderate persistent asthma and co-morbid seasonal allergic rhinitis whose asthma is inadequately controlled by their current asthma...

  • Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Burge P S; Calverley P M A; Jones P W; Spencer S; Anderson J A // Thorax;Aug2003, Vol. 58 Issue 8, p654 

    BACKGROUND: A trial of corticosteroids has been recommended for all patients with chronic obstructive pulmonary disease (COPD), with the subsequent "response" determining the treatment selected. This approach assumes that patients can be reliably divided into responder and non-responder groups....

  • Allergic rhinitis: evidence for impact on asthma. Thomas, Mike // BMC Pulmonary Medicine;2006 Supplement 1, Vol. 6, pS4 

    Background: This paper reviews the current evidence indicating that comorbid allergic rhinitis may have clinically relevant effects on asthma. Discussion: Allergic rhinitis is very common in patients with asthma, with a reported prevalence of up to 100% in those with allergic asthma. While the...

  • Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand. Johansson, Maria; Hall, Jason; Reith, David; Jackson, Pam; Tilyard, Murray // European Journal of Clinical Pharmacology;Sep2003, Vol. 59 Issue 5/6, p483 

    Objective. To compare the dispensed volumes and prescribed doses for inhaled corticosteroids (ICS) for children in New Zealand. Design. Longitudinal analysis of prescribing trends using the Royal New Zealand College of General Practitioners Research Unit database and the Pharm Warehouse database...

  • Bronchial Asthma -- Patient Expectations and the Role in Asthma Care. Scott, P. // West Indian Medical Journal;Jun2009, Vol. 58 Issue 3, p193 

    The author reflects on the progress in treatment bronchial asthma. The author says that the focus on asthma care has transformed from solely focusing on symptom relief to a result-driven philosophy. The author notes that the use of inhaled corticosteroids has remained significantly below the...

  • Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: A randomized controlled trial. Yousef, Ejaz; Hossain, Jobayer; Mannan, Susan; Skorpinski, Edward; McGeady, Stephen // Allergy & Asthma Proceedings;Nov/Dec2012, Vol. 33 Issue 6, p508 

    Various studies have examined the efficacy of a temporary increase in the dose of inhaled corticosteroids (ICSs) during acute asthma exacerbations with conflicting results. This study was designed to investigate the efficacy of high-dose ICSs in controlling asthma exacerbations in children. Data...

  • Validity of performance indicators for assessing prescribing quality: the case of asthma. Pont, Lisa G.; Denig, Petra; van der Molen, Thys; van der Veen, Willem Jan; Haaijer-Ruskamp, Flora M. // European Journal of Clinical Pharmacology;Jan2004, Vol. 59 Issue 11, p833 

    Objectives. The aim of this study was to assess the concurrent validity between the identification of sub-optimal treatment based on clinical information and computer generated indicators. Indicators that are associated with sub-optimal treatment in one of the four steps of asthma management...

  • Acute asthma. FitzGerald, Mark // BMJ: British Medical Journal (International Edition);10/13/2001, Vol. 323 Issue 7317, p841 

    Aetiology/risk factors Most people with asthma are atopic; exposure to certain stimuli initiates inflammation and structural changes in airways, causing airway hyperresponsiveness and variable airflow obstruction, which in turn cause most asthma symptoms. Stimuli include environmental...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics